Latest News of CDMO
Avid Bioservices, Inc. (CDMO): This Small-Cap Healthcare Stock Is A Good Buy Right Now
Avid Bioservices, Inc. (NASDAQ:CDMO) is a top small-cap healthcare stock due to its growth in biopharmaceutical manufacturing. With 31 hedge fund holders and positive analyst sentiment, the stock is e...
Does Avid Bioservices (CDMO) have Hidden Potential Despite Current Weakness?
Laughing Water Capital's Q2 2024 investor letter reported a 2.5% return for Class A interests, outperforming SP500TR and R2000. The firm focuses on unique market opportunities, with top holdings like ...
Agilent to Acquire Canadian CDMO BIOVECTRA for $925 Million
Agilent Technologies is acquiring Canadian CDMO BIOVECTRA for $925 million to strengthen its biopharma solutions, expand services, and enhance expertise in areas like ADCs and HPAPIs....
-
German CDMO outlays $980m on GLP-1 manufacturing expansion
By Yahoo! Finance | 2 months agoGerman CDMO Corden Pharma is investing €900m to expand its diabetes drug manufacturing capabilities, focusing on GLP-1 peptide manufacturing due to rising demand....
-
Those who invested in Avid Bioservices (NASDAQ:CDMO) five years ago are up 104%
By Yahoo! Finance | 3 months agoInvesting in stocks can lead to both gains and losses. Avid Bioservices, Inc. saw its share price rise significantly over the years despite lack of profitability. With strong revenue growth, the compa...